Preclinical drug testing platform integrating Organ-on-Chip (OoC) technologies and computational biology to optimize lead selection and clinical trial design.

Javelin Biotech offers the Liver Tissue Chip platform for sale, allowing customers to run studies in their own facilities. In addition, Javelin works with clients to develop new MPS tissue models and protocols for new Contexts of Use. Engage Javelin to develop new human tissue assays for safety, efficacy, and mechanism of action studies. Computational biology and Machine Learning algorithms translate experimental results into predictions that impact IND submissions and clinical trial designs.

Tissue Chip models include: liver, gut, and kidney for DMPK, PB/PK, toxicity, drug-drug interaction (DDI), mechanism of action, and other tests.

Javelin is able to test small molecules, biologics, and immuno-therapies. Pharmacovigilance.

Contact Javelin Biotech to discuss studies that will grow your insight and understanding of your lead candidates and build confidence as you decide which compounds to advance through development, which to further develop, and which to abandon.